Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial)

NCT05910476 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Dyslipidemias

Interventions

DRUG: a high dose of statin/ezetimib

Sponsor

Yonsei University

Collaborators

dotter